The Polish Development Fund (PFR), a state-run investment vehicle, will help finance the project, its CEO Paweł Borys told the media.
Paweł Borys. Photo: Polish Radio
He added that as a result Poland would join the group of countries where COVID-19 vaccines are produced.
Mabion said it had clinched a deal with Novavax for the transfer of know-how in the second quarter of this year and for technology tests to produce an antigen for a COVID-19 vaccine candidate.
The company added that it had also signed an agreement with the Polish Development Fund under which the latter would invest up to PLN 40 million (EUR 8.8 million, USD 10.6 million) to increase Mabion’s production capacity.
A Novavax vaccine is currently in the process of being registered by the European Medicines Agency, the EU's drug regulator, Poland’s PAP news agency reported.
Source: PAP, mabion.eu
Click on the ‘Play' button above for an audio report